About the Authors

Keita Tokumitsu

Roles Conceptualization, Data curation, Project administration, Writing – original draft

Affiliations Department of Neuropsychiatry, Towada City Hospital, Towada, Aomori, Japan, Department of Psychiatry, Dokkyo Medical University School of Medicine, Mibu, Tochigi, Japan

Norio Yasui-Furukori

Roles Writing – review & editing

furukori@dokkyomed.ac.jp

Affiliation Department of Psychiatry, Dokkyo Medical University School of Medicine, Mibu, Tochigi, Japan

Junko Takeuchi

Roles Writing – review & editing

Affiliation Department of Neuropsychiatry, Towada City Hospital, Towada, Aomori, Japan

Koji Yachimori

Roles Writing – review & editing

Affiliation Department of Neuropsychiatry, Towada City Hospital, Towada, Aomori, Japan

Norio Sugawara

Roles Methodology, Writing – review & editing

Affiliation Department of Psychiatry, Dokkyo Medical University School of Medicine, Mibu, Tochigi, Japan

Yoshio Terayama

Roles Writing – review & editing

Affiliation Department of Radiology, Towada City Hospital, Towada, Aomori, Japan

Nobuyuki Tanaka

Roles Writing – review & editing

Affiliation Department of Radiology, Towada City Hospital, Towada, Aomori, Japan

Tatsunori Naraoka

Roles Writing – review & editing

Affiliation Department of Radiology, Towada City Hospital, Towada, Aomori, Japan

Kazutaka Shimoda

Roles Writing – review & editing

Affiliation Department of Psychiatry, Dokkyo Medical University School of Medicine, Mibu, Tochigi, Japan

Competing Interests

Norio Yasui-Furukori has been a speaker for Dainippon Sumitomo Pharmaceutical, Mochida Pharmaceutical, and MSD. Kazutaka Shimoda has received research support from Meiji Seika Pharma Co., Pfizer Inc., Dainippon Sumitomo Pharma Co., Ltd., Daiichi Sankyo Co., Otsuka Pharmaceutical Co., Ltd., Astellas Pharma Inc., Novartis Pharma K.K., Eisai Co., Ltd., Takeda Pharmaceutical Co., Ltd. and honoraria from Mitsubishi Tanabe Pharma Corporation, Meiji Seika Pharma Co., Ltd., Dainippon Sumitomo Pharma Co., Ltd., Takeda Pharmaceutical Co., Shionogi & Co., Ltd., Daiichi Sankyo Co., Pfizer Inc. and Eisai Co., Ltd. The companies had no role in the study design, the data collection or analysis, the decision to publish, or the preparation of the manuscript. The remaining authors declare that they have no competing interests to report. This does not alter our adherence to PLOS ONE policies on sharing data and materials.